메뉴 건너뛰기




Volumn 14, Issue 1, 2016, Pages 205-210

Management of coagulopathy associated with postpartum hemorrhage: Guidance from the SSC of the ISTH

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PLACEBO; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 7A; PROTHROMBIN; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

EID: 84955203834     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13174     Document Type: Article
Times cited : (116)

References (51)
  • 1
    • 84893636958 scopus 로고    scopus 로고
    • 9th Annual Report (data from 2011). Accessed 16 November 2015.
    • Lennox C, Marr L. Scottish confidential audit of severe maternal morbidity. 9th Annual Report (data from 2011). http://healthcareimprovementscotland.org/his/idoc.ashx?docid=5fb640e2-d079-48cc-ad49-a58f6929b685&version=-1. 2013. Accessed 16 November 2015.
    • (2013) Scottish confidential audit of severe maternal morbidity
    • Lennox, C.1    Marr, L.2
  • 3
    • 72349087832 scopus 로고    scopus 로고
    • Green-top guideline No. 52, 2013. Accessed 16 November 2015.
    • Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top guideline No. 52, 2009. http://www.rcog.org.uk/files/rcog-corp/GT52PostpartumHaemorrhage0411.pdf 2013. Accessed 16 November 2015.
    • (2009) Prevention and management of postpartum haemorrhage
  • 4
    • 84924709643 scopus 로고    scopus 로고
    • Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety
    • Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol 2015; 212: 272-80.
    • (2015) Am J Obstet Gynecol , vol.212 , pp. 272-280
    • Shields, L.E.1    Wiesner, S.2    Fulton, J.3    Pelletreau, B.4
  • 5
    • 84891623481 scopus 로고    scopus 로고
    • How we manage the haematological aspects of major obstetric haemorrhage
    • Allard S, Green L, Hunt BJ. How we manage the haematological aspects of major obstetric haemorrhage. Br J Haematol 2014; 164: 177-88.
    • (2014) Br J Haematol , vol.164 , pp. 177-188
    • Allard, S.1    Green, L.2    Hunt, B.J.3
  • 6
    • 84925226535 scopus 로고    scopus 로고
    • Haemostatic management of obstetric haemorrhage
    • Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia 2015; 70: 78-86.
    • (2015) Anaesthesia , vol.70 , pp. 78-86
    • Collis, R.E.1    Collins, P.W.2
  • 7
    • 84875137025 scopus 로고    scopus 로고
    • Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism)
    • Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thromb Res 2013; 131(Suppl. 1): S32-4.
    • (2013) Thromb Res , vol.131 , pp. S32-S34
    • Levi, M.1
  • 8
    • 67349246760 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation in obstetric disorders and its acute haematological management
    • Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009; 23: 167-76.
    • (2009) Blood Rev , vol.23 , pp. 167-176
    • Thachil, J.1    Toh, C.H.2
  • 9
    • 0014961978 scopus 로고
    • Coagulation and fibrinolytic mechanisms during and after normal childbirth
    • Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J 1970; 2: 200-3.
    • (1970) Br Med J , vol.2 , pp. 200-203
    • Bonnar, J.1    McNicol, G.P.2    Douglas, A.S.3
  • 11
    • 84908632028 scopus 로고    scopus 로고
    • Fibrin-based clot formation an early and rapidly biomarker for progression of postpartum hemorrhage: a prospective study
    • Collins PW, Lilley G, Bruynseels D. Fibrin-based clot formation an early and rapidly biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124: 585-95.
    • (2014) Blood , vol.124 , pp. 585-595
    • Collins, P.W.1    Lilley, G.2    Bruynseels, D.3
  • 13
    • 84869459194 scopus 로고    scopus 로고
    • Haemostatic monitoring during postpartum haemorrhage and implications for management
    • Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012; 109: 851-63.
    • (2012) Br J Anaesth , vol.109 , pp. 851-863
    • Solomon, C.1    Collis, R.E.2    Collins, P.W.3
  • 14
    • 77949569528 scopus 로고    scopus 로고
    • The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage
    • Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 2010; 19: 218-23.
    • (2010) Int J Obstet Anesth , vol.19 , pp. 218-223
    • Bell, S.F.1    Rayment, R.2    Collins, P.W.3    Collis, R.E.4
  • 16
    • 61849136778 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of disseminated intravascular coagulation
    • Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009; 145: 24-33.
    • (2009) Br J Haematol , vol.145 , pp. 24-33
    • Levi, M.1    Toh, C.H.2    Thachil, J.3    Watson, H.G.4
  • 17
    • 79953280012 scopus 로고    scopus 로고
    • Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion
    • Afshari A, Wikkelsø A, Brok J, Møller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; 16: CD007871.
    • (2011) Cochrane Database Syst Rev , vol.16 , pp. CD007871
    • Afshari, A.1    Wikkelsø, A.2    Brok, J.3    Møller, A.M.4    Wetterslev, J.5
  • 18
    • 84920861857 scopus 로고    scopus 로고
    • Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage
    • Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70: 166-75.
    • (2015) Anaesthesia , vol.70 , pp. 166-175
    • Mallaiah, S.1    Barclay, P.2    Harrod, I.3    Chevannes, C.4    Bhalla, A.5
  • 19
    • 84864450589 scopus 로고    scopus 로고
    • Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage
    • De Lange NM, Lancé MD, de Groot R, Beckers EAM, Henskens YM, Scheepers HCJ. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv 2012; 67: 426-35.
    • (2012) Obstet Gynecol Surv , vol.67 , pp. 426-435
    • De Lange, N.M.1    Lancé, M.D.2    de Groot, R.3    Beckers, E.A.M.4    Henskens, Y.M.5    Scheepers, H.C.J.6
  • 24
    • 84929458946 scopus 로고    scopus 로고
    • How I treat postpartum hemorrhage
    • Pavord S, Maybury H. How I treat postpartum hemorrhage. Blood 2015; 125: 2759-70.
    • (2015) Blood , vol.125 , pp. 2759-2770
    • Pavord, S.1    Maybury, H.2
  • 27
  • 28
    • 84929457152 scopus 로고    scopus 로고
    • Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage
    • De Lloyd L, Collins PW, Kaye A, Collis RE. Early fibrinogen as a predictor of red cell requirements during postpartum haemorrhage. Int J Obstet Anesth 2012; 21: S13.
    • (2012) Int J Obstet Anesth , vol.21 , pp. S13
    • De Lloyd, L.1    Collins, P.W.2    Kaye, A.3    Collis, R.E.4
  • 32
    • 78549237206 scopus 로고    scopus 로고
    • Fibrinogen concentrate use during major obstetric haemorrhage
    • Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia 2010; 65: 1229-30.
    • (2010) Anaesthesia , vol.65 , pp. 1229-1230
    • Glover, N.J.1    Collis, R.E.2    Collins, P.3
  • 34
    • 45349083292 scopus 로고    scopus 로고
    • Fibrinogen concentrate for acquired hypofibrinogenaemic states
    • Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008; 18: 151-7.
    • (2008) Transfus Med , vol.18 , pp. 151-157
    • Weinkove, R.1    Rangarajan, S.2
  • 37
    • 84855161245 scopus 로고    scopus 로고
    • Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products
    • Shields LE, Smalarz K, Reffigee L, Mugg S, Burdumy TJ, Propst M. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol 2011; 205: 368.
    • (2011) Am J Obstet Gynecol , vol.205 , pp. 368
    • Shields, L.E.1    Smalarz, K.2    Reffigee, L.3    Mugg, S.4    Burdumy, T.J.5    Propst, M.6
  • 40
    • 0029130705 scopus 로고
    • Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates
    • Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5.
    • (1995) Anesth Analg , vol.81 , pp. 360-365
    • Hiippala, S.T.1    Myllyla, G.J.2    Vahtera, E.M.3
  • 42
    • 1842610163 scopus 로고    scopus 로고
    • Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients
    • Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
    • (2004) Br J Haematol , vol.125 , pp. 69-73
    • Chowdhury, P.1    Saayman, A.G.2    Paulus, U.3    Findlay, G.P.4    Collins, P.W.5
  • 43
    • 77955497501 scopus 로고    scopus 로고
    • Tranexamic acid for preventing postpartum haemorrhage
    • Novikova N, Hofmeyr GL. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010; 7: CD007872.
    • (2010) Cochrane Database Syst Rev , vol.7 , pp. CD007872
    • Novikova, N.1    Hofmeyr, G.L.2
  • 46
    • 79952311766 scopus 로고    scopus 로고
    • Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study
    • Gungorduk K, Yildirim G, Asicioğlu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 2011; 28: 233-9.
    • (2011) Am J Perinatol , vol.28 , pp. 233-239
    • Gungorduk, K.1    Yildirim, G.2    Asicioğlu, O.3    Gungorduk, O.C.4    Sudolmus, S.5    Ark, C.6
  • 47
    • 77952605810 scopus 로고    scopus 로고
    • The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
    • Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40.
    • (2010) Trials , vol.11 , pp. 40
    • Shakur, H.1    Elbourne, D.2    Gülmezoglu, M.3    Alfirevic, Z.4    Ronsmans, C.5    Allen, E.6    Roberts, I.7
  • 50
    • 78049498149 scopus 로고    scopus 로고
    • Safety of recombinant activated factor VII in randomized clinical trials
    • Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791-800.
    • (2010) N Engl J Med , vol.363 , pp. 1791-1800
    • Levi, M.1    Levy, J.H.2    Andersen, H.F.3    Truloff, D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.